Capricor Therapeutics CAPR
NASDAQ CAPR
$11.22 +2.35 (+26.49%)
At close: Nov 11, 2026 · 4:00 PM EST

Capricor Therapeutics (CAPR) Receivables (2020 - 2025)

Updated

Capricor Therapeutics (CAPR) recorded Receivables of $59,167 in Q4 2025, down 99.8% from $30.37 million a year earlier.

Analysis

Capricor Therapeutics (CAPR) Receivables (2020 - 2025) Analysis & Trends

  • Across earlier years, Receivables came in at $30.37 million in FY2024 (+49.1%) and $20.37 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 25.23 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 18.99 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 13.51 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 12.74 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 16.16 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 10.35 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 5.01 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 14.19 Bn
10 Capricor Therapeutics 515.69 Mn -516.56 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 59,167.00
Sep 30, 2025 118,334.00
Jun 30, 2025 119,018.00
Mar 31, 2025 119,668.00
Dec 31, 2024 30.37 Mn
Sep 30, 2024 819,364.00
Jun 30, 2024 739,950.00
Mar 31, 2024 738,000.00
Dec 31, 2023 20.37 Mn
Sep 30, 2023 1.10 Mn
Jun 30, 2023 1.10 Mn
Mar 31, 2023 1.10 Mn
Dec 31, 2022 1.10 Mn
Sep 30, 2022 1.10 Mn
Jun 30, 2022 1.10 Mn
Mar 31, 2022 713,994.00
Dec 31, 2021 783,500.00
Sep 30, 2021 360,356.00
Dec 31, 2020 56,000.00
API Access

Capricor Therapeutics Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=CAPR&period=max&api_key=YOUR_API_KEY